Atlas Trials

Itacitinib and Tocilizumab for Steroid Refractory Acute Graft Versus Host Disease

Clinical trial NCT04070781 · TERMINATED

Trial details

NCT number
NCT04070781
Sponsor
Columbia University
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Steroid Refractory GVHDGraft Vs Host Disease
Start date
2020-01-20
Primary completion
2021-12-13
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.